Regeneron Pharmaceuticals (REGN) R&D Expenses & History | Stock Alarm

Demo Sign up Log In

Regeneron Pharmaceuticals · R&D Expenses

REGN R&D Expenses

Latest reported$6.46Bperiod endingJun 30, 2026

REGN R&D Expenses ($0.00 → $6.46B)

Annual R&D Expenses

High-resolution chart · PNG

REGN r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	5,850,200,000
Dec 31, 2024	5,233,000,000
Dec 31, 2023	3,986,700,000
Dec 31, 2022	3,056,100,000
Dec 31, 2021	2,621,900,000
Dec 31, 2020	2,499,100,000
Dec 31, 2019	2,239,700,000
Dec 31, 2018	2,037,900,000
Dec 31, 2017	1,929,675,000
Dec 31, 2016	1,947,550,000
Dec 31, 2015	1,545,668,000
Dec 31, 2014	1,218,667,000
Dec 31, 2013	818,743,000
Dec 31, 2012	588,614,000
Dec 31, 2011	498,424,000
Dec 31, 2010	469,565,000
Dec 31, 2009	384,515,000
Dec 31, 2008	266,728,999
Dec 31, 2007	190,126,000
Dec 31, 2006	122,122,000
Dec 31, 2005	137,922,000
Dec 31, 2004	136,095,000
Dec 31, 2003	136,024,000
Dec 31, 2002	124,926,000
Dec 31, 2001	91,540,000
Dec 31, 2000	56,256,000
Dec 31, 1999	44,900,000
Dec 31, 1998	37,000,000
Dec 31, 1997	27,800,000
Dec 31, 1996	28,300,000
Dec 31, 1995	23,300,000
Dec 31, 1994	39,700,000
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.